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LETTERS TO THE EDITOR 
Impregnation of sewing ring with antibiotics to 
avoid prosthetic valve endocarditis 
To the Editor: 
We read with great interest the original article by 
French and associates 1 regarding rifampicin impregna- 
tion of a mechanical valve sewing ring to prevent early 
endocarditis. Prosthetic valve endocarditis (PVE) is still 
a dangerous complication of cardiac operations. The 
reported incidence in the literature ranges from 1% to 
9% in patients undergoing heart valve replacement. 
Direct contamination during the operation has been 
suggested as a possible cause of early and late postop- 
erative PVE. Systemic antibiotic prophylaxis fails to 
achieve a sufficient antibiotic concentration in the 
sewing ring of the prosthesis, where PVE usually devel- 
ops. Another study by Karck and colleagues 2 showed a 
significant increase in the antibiotic concentration i  
the sewing ring after prosthetic valve pretreatment with 
a fibrin sealant compound. 
In 1971 we began pretreating prosthetic valves by 
immersing them in antibiotic solution before implanting 
them in patients. From 1971 to December 1991, 1262 
patients (504 men and 758 women, mean age 42.3 years, 
standard eviation 11.1; range 20 to 71 years) underwent 
heart valve replacement a our institution) 
Most of the patients (1250/1262; 99%) had elective 
operations. All patients but two received mechanical 
valves. A variety of systemic antibiotics were used for 
prophylaxis through the years at induction of anesthesia 
(penicillin, kanamycin, oxacillin, ampicillin, piperacil- 
lin, and ceftazidime). Before the prosthesis was low- 
ered, the sewing ring was immersed in 50 ml of saline 
solution containing the same antibiotic used at induc- 
tion. The sewing ring was generally soaked completely 
within 2 to 3 minutes. Parenteral antibiotic administra- 
tion was maintained uring the following 4 postopera- 
tive days. 
A complete follow-up was obtained in 964 patients 
(76.4%) by means of examination, questionnaires sent to 
their cardiologists, or telephone contact. 
The incidence of early PVE was only one case (0.08%) 
2 months after valve implantation, resulting from Staphy- 
lococcus epidermidis, and the patient underwent a success- 
ful second operation. 
Late PVE was observed in 12 cases (0.95%; Streptococ- 
cus, n = 5; Gram negative Haemophilus and Brucella, n = 
2; Candida, n = 1; indeterminate, n = 4). Seven patients 
were medically treated, none of whom died, but five 
underwent a second operation with two operative deaths 
(15%). 
In this large series of heart valve replacements he low 
incidence of early PVE can be attributed partially to the 
small number of emergency operations (1% only), but we 
believe that soaking the valve in antibiotic solution before 
implantation was helpful as well. 
Early PVE is almost always related to direct contami- 
nation during the operative procedure or to native valve 
endocarditis. The prosthesis sewing ring is usually the site 
of implantation of the etiologic agent because the low 
blood flow at the interface between the prosthesis and the 
valve anulus prevents adequate contact with the antibiotic 
present in the serum. 
We believe that increasing the concentration of anti- 
biotics in the valve sewing ring or vascular prosthesis is 
the correct philosophy to decrease this complication 
after heart valve implantation, and we congratulate 
French and colleagues for their idea to increase the 
concentration of antibiotics in the prosthetic tissue. 
Guglielmo M. Actis Dato, MD 
M. Cavaglia, MD 
G. A. Poletti, MD 
Italian Institution of Cardiac Surgery 
Via Genova, 4 
Torino 10126, Italy 
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Reply to the Editor." 
The authors of this letter have described a method of 
passively soaking all heart valves in a variety of solu- 
tions containing antibiotics before valve implantation. 
They have achieved a low incidence of early endocar- 
ditis in follow-up, which they recognize was incomplete. 
Although we agree that early postoperative endocar- 
ditis is due to perioperative or intraoperative contami- 
nation of the valve, our results failed to demonstrate 
rifampicin retention in vivo when we passively soaked 
the unsealed sewing ring. This is also implied in the 
article by Karck and associates, 1 who used a gentamicin 
derivative. We believe, with others, that rifampicin will 
bind to a protein sealant incorporated into the Dacron 
sewing ring, and in our study we found the best 
retention occurred when the sewing ring material was 
first sealed by being autoclaved in blood before being 
passively soaked in a solution of rifampicin. To do this 
adds significantly to the crossclamp time. We proposed 
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